risks with glp 1 GLP-1 Medications and Muscle Loss: The Hidden Risk to Strength and Injury Recovery Along with rapid weight loss,

Key points for patient discussions include: GLP-1 medications are FDA-approved only for type 2 diabetes and, for specific agents, chronic weight management Research on cognitive benefits is ongoing but not yet conclusive These medications have known side effects that require monitoring Dementia prevention involves multiple lifestyle and medical factors Women of childbearing potential should use effective contraception while taking GLP-1 medications, as safety in pregnancy is not established Patients should seek medical evaluation if they experience: New or worsening memory problems or confusion (which may warrant cognitive screening, laboratory tests including thyroid and vitamin B12, and possible referral to neurology) Severe gastrointestinal symptoms while taking GLP-1 medications Signs of dehydration (dizziness, decreased urination, dry mouth) Persistent abdominal pain that could indicate pancreatitis Neck mass or hoarseness (thyroid concerns) Sudden vision changes (potential retinopathy complications) Right upper quadrant pain, fever, or yellowing of skin/eyes (gallbladder or liver issues) Caregivers of individuals with established dementia should discuss with healthcare providers whether continuing or initiating GLP-1 therapy is appropriate, considering the person's ability to manage injections, report side effects, and maintain adequate nutrition

Light exposure can degrade the preservative and potentially other components

Seek same-day urgent care for sudden vision loss, numerous new floaters, flashes of light, a curtain or shadow across your visual field, or distorted vision where straight lines appear wavy

Its also known as semaglutide, which is its generic name

Aktuelle Onkologie, Band 27: Hormone, Antihormone, Zytostatika zur adjuvanten Therapie des Mammakarzinoms

Notably, this strategy not only controlled primary melanoma but also inhibited metastatic spread, underscoring its systemic immunomodulatory capacity (101)